Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous lidocaine versus placebo for gastrointestinal recovery after colorectal surgery
2017-003835-12Phase 3Unknown
- Sponsor
- University of Edinburgh
- Start
- Jan 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in colorectal cancer (CRC) and diverticular disease comparing Intravenous lidocaine with Placebo (2 arms). Primary endpoint: Proportion with GI-3 recovery at 72 hours. Status: unknown.
02
Drugs
lidocaine
03
Conditions
colorectal cancer (CRC)diverticular disease
Beyond the preview
Go deeper on 2017-003835-12.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-003835-12.